These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22024773)

  • 21. Hormonal, pituitary magnetic resonance, LHX4 and HESX1 evaluation in patients with hypopituitarism and ectopic posterior pituitary lobe.
    Melo ME; Marui S; Carvalho LR; Arnhold IJ; Leite CC; Mendonça BB; Knoepfelmacher M
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):95-102. PubMed ID: 17201807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene.
    Mendonca BB; Osorio MG; Latronico AC; Estefan V; Lo LS; Arnhold IJ
    J Clin Endocrinol Metab; 1999 Mar; 84(3):942-5. PubMed ID: 10084575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The c.301_302delAG PROP1 gene mutation in Romanian patients with multiple pituitary hormone deficiency.
    Lazea C; Grigorescu-Sido P; Popp R; Legendre M; Amselem S; Al-Khzouz C; Bucerzan S; Creţ V; Crişan M; Brad C
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):993-8. PubMed ID: 25581745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI findings and genotype analysis in patients with childhood onset growth hormone deficiency--correlation with severity of hypopituitarism.
    Zimmermann A; Schenk JP; Grigorescu Sido P; Pfaffle R; Lazea C; Zimmermann T; Heinrich U; Weber MM; Bettendorf M
    J Pediatr Endocrinol Metab; 2007 May; 20(5):587-96. PubMed ID: 17642419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Case Seminar. Peculiar prolactinomas in patients with pituitary developmental gene mutations: from an adult endocrinologist perspective.
    Doknic M; Pekic S; Civcic M; Popovic V
    Hormones (Athens); 2012; 11(2):189-98. PubMed ID: 22801565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3+1/+2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency.
    de Graaff LC; Argente J; Veenma DC; Drent ML; Uitterlinden AG; Hokken-Koelega AC
    Horm Res Paediatr; 2010; 73(5):363-71. PubMed ID: 20389107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of novel PROP1 mutations associated with combined pituitary hormone deficiency (CPHD).
    Kelberman D; Turton JP; Woods KS; Mehta A; Al-Khawari M; Greening J; Swift PG; Otonkoski T; Rhodes SJ; Dattani MT
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):96-103. PubMed ID: 19128366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene.
    Pernasetti F; Toledo SP; Vasilyev VV; Hayashida CY; Cogan JD; Ferrari C; Lourenço DM; Mellon PL
    J Clin Endocrinol Metab; 2000 Jan; 85(1):390-7. PubMed ID: 10634415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary enlargement in patients with PROP1 gene inactivating mutation represents cystic hyperplasia of the intermediate pituitary lobe. Histopathology and over 10 years follow-up of two patients.
    Zygmunt-Górska A; Starzyk J; Adamek D; Radwańska E; Sucharski P; Herman-Sucharska I; Pietrzyk JJ
    J Pediatr Endocrinol Metab; 2009 Jul; 22(7):653-60. PubMed ID: 19774847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in PROP1 cause familial combined pituitary hormone deficiency.
    Wu W; Cogan JD; Pfäffle RW; Dasen JS; Frisch H; O'Connell SM; Flynn SE; Brown MR; Mullis PE; Parks JS; Phillips JA; Rosenfeld MG
    Nat Genet; 1998 Feb; 18(2):147-9. PubMed ID: 9462743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical lessons learned in constitutional hypopituitarism from two decades of experience in a large international cohort.
    Jullien N; Saveanu A; Vergier J; Marquant E; Quentien MH; Castinetti F; Galon-Faure N; Brauner R; Marrakchi Turki Z; Tauber M; El Kholy M; Linglart A; Rodien P; Fedala NS; Bergada I; Cortet-Rudelli C; Polak M; Nicolino M; Stuckens C; Barlier A; Brue T; Reynaud R;
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):277-289. PubMed ID: 33098107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined pituitary hormone deficiency caused by PROP1 mutations: update 20 years post-discovery.
    Correa FA; Nakaguma M; Madeira JLO; Nishi MY; Abrão MG; Jorge AAL; Carvalho LR; Arnhold IJP; Mendonça BB
    Arch Endocrinol Metab; 2019 May; 63(2):167-174. PubMed ID: 31090814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion.
    Agarwal G; Bhatia V; Cook S; Thomas PQ
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4556-61. PubMed ID: 11134108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular analysis of LHX3 and PROP-1 in pituitary hormone deficiency patients with posterior pituitary ectopia.
    Sloop KW; Walvoord EC; Showalter AD; Pescovitz OH; Rhodes SJ
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2701-8. PubMed ID: 10946868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional SNPs within the intron 1 of the PROP1 gene contribute to combined growth hormone deficiency (CPHD).
    Godi M; Mellone S; Tiradani L; Marabese R; Bardelli C; Salerno M; Prodam F; Bellone S; Petri A; Momigliano-Richiardi P; Bona G; Giordano M
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1791-7. PubMed ID: 22745233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auxological and endocrine phenotype in a population-based cohort of patients with PROP1 gene defects.
    Lebl J; Vosáhlo J; Pfaeffle RW; Stobbe H; Cerná J; Novotná D; Zapletalová J; Kalvachová B; Hána V; Weiss V; Blum WF
    Eur J Endocrinol; 2005 Sep; 153(3):389-96. PubMed ID: 16131601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital combined pituitary hormone deficiency attributable to a novel PROP1 mutation (467insT).
    Nose O; Tatsumi K; Nakano Y; Amino N
    J Pediatr Endocrinol Metab; 2006 Apr; 19(4):491-8. PubMed ID: 16759034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency.
    Vallette-Kasic S; Barlier A; Teinturier C; Diaz A; Manavela M; Berthezène F; Bouchard P; Chaussain JL; Brauner R; Pellegrini-Bouiller I; Jaquet P; Enjalbert A; Brue T
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4529-35. PubMed ID: 11549703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell proliferation and vascularization in mouse models of pituitary hormone deficiency.
    Ward RD; Stone BM; Raetzman LT; Camper SA
    Mol Endocrinol; 2006 Jun; 20(6):1378-90. PubMed ID: 16556738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons from monogenic causes of growth hormone deficiency.
    Brue T; Saveanu A; Jullien N; Fauquier T; Castinetti F; Enjalbert A; Barlier A; Reynaud R
    Ann Endocrinol (Paris); 2017 Jun; 78(2):77-79. PubMed ID: 28483366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.